-
RenovoRx’s RenovoCath System Gains Traction: Expanding to Nine Leading Cancer Centers
NASDAQ: $RNXT The landscape of localized cancer treatment is witnessing significant evolution, and RenovoRx, Inc. is at the forefront of this shift. A recent announcement highlights a major milestone for the company: the expansion of the commercial adoption of its innovative RenovoCath® system across nine active cancer centers in the United States. This expansion signifies…
-
Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolR?-targeted ADC, on January 4, 2024
NASDAQ: $STRO 1. Introduction to Sutro Biopharma’s Investor Webcast Welcome to the article covering the upcoming investor webcast hosted by Sutro Biopharma on January 4, 2024. This webcast aims to highlight the potential multi-cancer opportunity associated with Luvelta, a promising FolR?-targeted Antibody-Drug Conjugate (ADC) developed by Sutro Biopharma. In this article, we will delve into…